CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy

被引:0
|
作者
Xiaohui Zhang
Liren Wang
Mingyao Liu
Dali Li
机构
[1] ShanghaiKeyLaboratoryofRegulatoryBiology,InstituteofBiomedicalSciencesandSchoolofLifeSciences,EastChinaNormalUniversity
关键词
D O I
暂无
中图分类号
学科分类号
摘要
CRISPR/Cas9 is a versatile genome-editing tool which is widely used for modifying the genome of both prokaryotic and eukaryotic organisms for basic research and applications. An increasing number of reports have demonstrated that CRISPR/Cas9-mediated genome editing is a powerful technology for gene therapy. Here, we review the recent advances in CRISPR/Cas9-mediated gene therapy in animal models via different strategies and discuss the challenges as well as future prospects.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] CRISPR/Cas9 technology as a potent molecular tool for gene therapy
    Karimian, Ansar
    Azizian, Khalil
    Parsian, Hadi
    Rafieian, Sona
    Shafiei-Irannejad, Vahid
    Kheyrollah, Maryam
    Yousefi, Mehdi
    Majidinia, Maryam
    Yousefi, Bahman
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) : 12267 - 12277
  • [22] In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges
    Mout, Rubul
    Ray, Moumita
    Lee, Yi-Wei
    Scaletti, Federica
    Rotello, Vincent M.
    [J]. BIOCONJUGATE CHEMISTRY, 2017, 28 (04) : 880 - 884
  • [23] Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing
    Jessica D. Gumerson
    Amal Alsufyani
    Wenhan Yu
    Jingqi Lei
    Xun Sun
    Lijin Dong
    Zhijian Wu
    Tiansen Li
    [J]. Gene Therapy, 2022, 29 : 81 - 93
  • [24] Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing
    Gumerson, Jessica D.
    Alsufyani, Amal
    Yu, Wenhan
    Lei, Jingqi
    Sun, Xun
    Dong, Lijin
    Wu, Zhijian
    Li, Tiansen
    [J]. GENE THERAPY, 2022, 29 (1-2) : 81 - 93
  • [25] Visualizing the Nucleome Using the CRISPR–Cas9 System: From in vitro to in vivo
    Liliya G. Maloshenok
    Gerel A. Abushinova
    Alexandra Yu. Ryazanova
    Sergey A. Bruskin
    Victoria V. Zherdeva
    [J]. Biochemistry (Moscow), 2023, 88 : S123 - S149
  • [26] Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application
    Sun, Bixi
    Chen, Hening
    Gao, Xiaoshu
    [J]. JOURNAL OF CONTROLLED RELEASE, 2021, 337 : 698 - 717
  • [27] The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
    Lin, Su-Ru
    Yang, Hung-Chih
    Kuo, Yi-Ting
    Liu, Chun-Jen
    Yang, Ta-Yu
    Sung, Ku-Chun
    Lin, You-Yu
    Wang, Hurng-Yi
    Wang, Chih-Chiang
    Shen, Yueh-Chi
    Wu, Fang-Yi
    Kao, Jia-Horng
    Chen, Ding-Shinn
    Chen, Pei-Jer
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2014, 3 : e186
  • [28] Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications
    Li, Yamin
    Glass, Zachary
    Huang, Mingqian
    Chen, Zheng-Yi
    Xu, Qiaobing
    [J]. BIOMATERIALS, 2020, 234
  • [29] In vivo mutagenesis of miRNA gene families using a scalable multiplexed CRISPR/Cas9 nuclease system
    Narayanan, Anand
    Hill-Teran, Guillermina
    Moro, Albertomaria
    Ristori, Emma
    Kasper, Dionna M.
    Roden, Christine A.
    Lu, Jun
    Nicoli, Stefania
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [30] Simple and Rapid In Vivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology
    Blasco, Rafael B.
    Karaca, Elif
    Ambrogio, Chiara
    Cheong, Taek-Chin
    Karayol, Emre
    Minero, Valerio G.
    Voena, Claudia
    Chiarle, Roberto
    [J]. CELL REPORTS, 2014, 9 (04): : 1219 - 1227